Ophthalmology · Fort Myers, FL
NPI
1043213051
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12381 S Cleveland Ave Ste 300
Fort Myers, FL, 33907
Phone (239) 939-1444
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
15,587 services
Medicare patients, 2024
2,368
Average age 78
Drug cost, 2024
$1.1M
5,750 prescriptions
Company payments, 2025
$1,688
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark S Gorovoy was code J2777 (injection, faricimab-svoa, 0.1 mg), 6,900 times for 24 patients. In total Mark S Gorovoy billed 15,587 services in 116 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 6,900 | 24 | $27.44 | $189K |
| 99213 Office E&M - Established | Office | 1,528 | 1,138 | $62.88 | $96K |
| 92250 Angiography | Office | 1,004 | 913 | $25.97 | $26K |
| 99214 Office E&M - Established | Office | 797 | 764 | $88.81 | $71K |
| 92014 Ophthalmological E&M | Office | 590 | 580 | $84.19 | $50K |
| 92134 Computerized Ophthalmic Imaging | Office | 564 | 455 | $28.00 | $16K |
| 92286 Standard X-ray | Office | 560 | 543 | $27.66 | $15K |
| 67028 Intravitreal Injection | Office | 324 | 74 | $85.15 | $28K |
| 92136 Ultrasound - Nonspecific | Office | 303 | 212 | $29.79 | $9,026 |
| 92083 Vision, Hearing, and Speech Services | Office | 293 | 289 | $45.77 | $13K |
| 92133 Computerized Ophthalmic Imaging | Office | 290 | 290 | $24.69 | $7,159 |
| J0178 Injection, aflibercept, 1 mg | Office | 252 | 30 | $658.93 | $166K |
| 66984 Cataract Surgery | Facility | 225 | 139 | $411.31 | $93K |
| 99204 Office E&M - New | Office | 215 | 215 | $114.11 | $25K |
| 66821 Cataract Surgery | Facility | 178 | 136 | $240.20 | $43K |
By year: 2022 $1.2M for 11,010 services; 2023 $1.2M for 12,455 services; 2024 $1.2M for 15,587 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark S Gorovoy prescribed most often to Medicare patients was Prednisolone Acetate, with 1,662 prescriptions and refills. In total Mark S Gorovoy wrote 5,750 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 1,662 | 2,672 | 627 | $73K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 662 | 1,641 | 240 | $11K |
| Latanoprost Generic | 554 | 1,280 | 177 | $6,615 |
| Ketorolac Tromethamine Generic | 512 | 774 | 264 | $11K |
| Moxifloxacin Moxifloxacin Hcl | 335 | 390 | 127 | $9,440 |
| Timolol Maleate Generic | 233 | 553 | 98 | $3,029 |
| Ciprofloxacin Hcl Generic | 201 | 222 | 116 | $2,071 |
| Fluorometholone Generic | 136 | 266 | 61 | $11K |
| Dexamethasone Sodium Phosphate Generic | 114 | 192 | 39 | $4,573 |
| Valacyclovir Valacyclovir Hcl | 106 | 227 | 40 | $4,399 |
| Brimonidine Tartrate Generic | 100 | 219 | 38 | $3,517 |
| Restasis Cyclosporine | 95 | 177 | 42 | $110K |
| Loteprednol Etabonate Generic | 89 | 202 | 42 | $16K |
| Dorzolamide Hcl Generic | 88 | 186 | 34 | $1,518 |
| Gatifloxacin Generic | 73 | 81 | 31 | $4,905 |
Brand drugs: 2,621 claims; generic drugs: 3,129 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark S Gorovoy $1,688 ($1,688 in general payments such as food, travel and fees) from 13 companies. The largest payer was Kowa Pharmaceuticals America, Inc. with $672.
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 1 | $672 |
| Alcon Vision LLC ALC | 7 | $318 |
| Abbvie Inc. ABBV | 11 | $216 |
| Harrow Eye, LLC | 4 | $101 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $86.78 |
| Dompe US, Inc. | 3 | $74.57 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $44.25 |
| Oyster Point Pharma, Inc. | 2 | $39.23 |
| Astellas Pharma US Inc 4503.T | 2 | $33.37 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $32.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.